Nutritional status is a prognostic factor for survival in ALS patients

被引:342
作者
Desport, JC [1 ]
Preux, PM
Truong, TC
Vallat, JM
Sautereau, D
Couratier, P
机构
[1] Ctr Hosp Univ Dupuytren, Serv Hepatogastroenterol, UF Nutr, F-87042 Limoges, France
[2] Ctr Hosp Univ Dupuytren, Neurol Serv, F-87042 Limoges, France
[3] Fac Med Limoges, Lab Biostat, F-87025 Limoges, France
关键词
ALS; motor neuron disease; prognosis; nutrition;
D O I
10.1212/WNL.53.5.1059
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To evaluate the occurrence of malnutrition in patients with ALS, to assess the relation of malnutrition to the neurologic deficit, and to determine the impact of nutritional status on patient survival. Background: Although ALS may be associated with significant malnutrition, the relative impact on patient survival has not yet been well established. Methods: In a prospective 7-month study of 55 ALS patients in a referral neurology practice, nutritional status was assessed by calculating body mass index. Neurologic evaluation includes four functional scores and identifies the form of disease onset. Slow vital capacity (VC) was also measured. Results: Occurrence of malnutrition in patients studied was 16.4%. Survival (using the Kaplan-Meier method) was worse for malnourished patients (p < 0.0001), with a 7.7-fold increased risk of death. Using multivariate analysis, only reduced VC (p < 0.0001) and malnutrition (p < 0.01) were found to have significant independent prognostic value. The degree of malnutrition is independent of neurologic scores and of forms of ALS onset. Conclusion: Nutritional surveillance of ALS patients is very important, both in bulbar-onset and spinal-onset patients.
引用
收藏
页码:1059 / 1063
页数:5
相关论文
共 28 条
  • [1] *ACTS, 1996, NEUROLOGY, V46, pA208
  • [2] andersen p, 1998, ENCY BIOSTATISTICS, P4452
  • [3] [Anonymous], AMYOTROPHIC LATERAL
  • [4] A CONTROLLED TRIAL OF RILUZOLE IN AMYOTROPHIC-LATERAL-SCLEROSIS
    BENSIMON, G
    LACOMBLEZ, L
    MEININGER, V
    BOUCHE, P
    DELWAIDE, C
    COURATIER, P
    BLIN, O
    VIADER, F
    PEYROSTPAUL, H
    DAVID, J
    MALOTEAUX, JM
    HUGON, J
    LATERRE, EC
    RASCOL, A
    CLANET, M
    VALLAT, JM
    DUMAS, A
    SERRATRICE, G
    LECHEVALLIER, B
    PEUCH, AJ
    NGUYEN, T
    SHU, C
    BASTIEN, P
    PAPILLON, C
    DURRLEMAN, S
    LOUVEL, E
    GUILLET, P
    LEDOUX, L
    ORVOENFRIJA, E
    DIB, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) : 585 - 591
  • [5] Brooks BR, 1996, ARCH NEUROL-CHICAGO, V53, P141
  • [6] CHAZOT F, 1986, Neuroepidemiology, V5, P39, DOI 10.1159/000110811
  • [7] COX DR, 1972, J R STAT SOC B, V34, P187
  • [8] MANIFESTATIONS OF ALS IN THE CRANIAL MOTOR NERVES - DYNAMETRIC, NEUROPATHOLOGIC, AND SPEECH MOTOR DATA
    DEPAUL, R
    ABBS, JH
    [J]. NEUROLOGIC CLINICS, 1987, 5 (02) : 231 - 250
  • [9] NATURAL-HISTORY OF AMYOTROPHIC-LATERAL-SCLEROSIS IN A DATABASE POPULATION - VALIDATION OF A SCORING SYSTEM AND A MODEL FOR SURVIVAL PREDICTION
    HAVERKAMP, LJ
    APPEL, V
    APPEL, SH
    [J]. BRAIN, 1995, 118 : 707 - 719
  • [10] JAMES WPT, 1988, EUR J CLIN NUTR, V42, P969